Resverlogix Corp wins Technology Pioneer Award

Guest Contributor
December 10, 2007

Resverlogix Corp is the only Canadian recipient of the 23 2008 Technology Pioneer Awards handed out by the World Economic Forum. The Calgary-based firm was recognized for its development of new molecules used in the treatment of atherosclerosis. Cardiovascular disease (CVD) is identified as the number one cause of death globally, with more than 18 million dead annually. Current therapies address only 30% of the risk associated with CVD and Resverlogix is aiming at the 70% of those still at risk. It was chosen for the award among 273 nominees nominated by venture capital and technology companies from around the world....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.